Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site
Nishiyama, Naotaka ; Kita, Yuki ; Ito, Katsuhiro ; Kato, Minoru ; Hatakeyama, Shingo ; Matsushita, Yuto ; Naito, Sei ; Miyake, Makito ; Nakanishi, Shotaro ; Kato, Yoichiro ; Shibuya, Tadamasa ; Hayashi, Tetsutaro ; Yasumoto, Hiroaki ; Yoshida, Takashi ; Uemura, Motohide ; Taoka, Rikiya ; Nishiyama, Hiroyuki ; Kobayashi, Takashi ; Kitamura, Hiroshi
Anticancer research, 2023-11, Vol.43 (11), p.5041-5050 [Periódico revisado por pares]Athens: International Institute of Anticancer Research
Texto completo disponível